The Co-Creation of a Psychosocial Support Website for Advanced Cancer Patients Obtaining a Long-Term Response to Immunotherapy or Targeted Therapy
Abstract
:1. Introduction
2. Materials and Methods
2.1. Design
2.2. Participants
2.3. Procedures
2.3.1. Planning
2.3.2. Website Design
2.3.3. Development
2.3.4. Evaluation
2.4. Measures
2.5. Analysis
2.5.1. Power Analysis
2.5.2. Quantitative Analysis
2.5.3. Qualitative Analysis
3. Results
3.1. Development
3.1.1. User Panel
3.1.2. Feedback on Design and Usability
3.1.3. Feedback on Feasibility
3.1.4. Prototype Modification
3.2. Evaluation
3.2.1. Study Sample
3.2.2. Psychological Distress and Resilience
3.2.3. Design and Usability
3.2.4. Feasibility
3.2.5. Final Adaptations
4. Discussion
4.1. Strengths and Limitations
4.2. Implications for Clinical Practice and Research
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
LTRs | Long-term responders |
PE | Psycho-education |
HADS | Hospital Anxiety Depression Scale |
BRS | Brief Resilience Scale |
SUS | System Usability Scale |
References
- Zwanenburg, L.C.; Suijkerbuijk, K.P.M.; van Dongen, S.I.; Koldenhof, J.J.; van Roozendaal, A.S.; van der Lee, M.L.; Schellekens, M.P.J. Living in the twilight zone: A qualitative study on the experiences of patients with advanced cancer obtaining long-term response to immunotherapy or targeted therapy. J. Cancer Surviv. 2022, 18, 750–760. [Google Scholar] [CrossRef] [PubMed]
- Kolsteren, E.E.M.; Deuning-Smit, E.; Chu, A.K.; van der Hoeven, Y.C.W.; Prins, J.B.; van der Graaf, W.T.A.; van Herpen, C.M.L.; van Oort, I.M.; Lebel, S.; Thewes, B.; et al. Psychosocial Aspects of Living Long Term with Advanced Cancer and Ongoing Systemic Treatment: A Scoping Review. Cancers 2022, 14, 3889. [Google Scholar] [CrossRef]
- Dunn, J.; Watson, M.; Aitken, J.F.; Hyde, M.K. Systematic review of psychosocial outcomes for patients with advanced melanoma. Psycho-Oncology 2017, 26, 1722–1731. [Google Scholar] [CrossRef]
- Farland, D.C. New lung cancer treatments (immunotherapy and targeted therapies) and their associations with depression and other psychological side effects as compared to chemotherapy. Gen. Hosp. Psychiatry 2019, 60, 148–155. [Google Scholar] [CrossRef] [PubMed]
- Lai-Kwon, J.; Heynemann, S.; Flore, J.; Dhillon, H.; Duffy, M.; Burke, J.; Briggs, L.; Leigh, L.; Mileshkin, L.; Solomon, B.; et al. Living with and beyond metastatic non-small cell lung cancer: The survivorship experience for people treated with immunotherapy or targeted therapy. J. Cancer Surviv. 2021, 15, 392–397. [Google Scholar] [CrossRef] [PubMed]
- Kamminga, N.C.; van der Veldt, A.A.; Joosen, M.C.; de Joode, K.; Joosse, A.; Grünhagen, D.J.; Nijsten, T.E.; Wakkee, M.; Lugtenberg, M. Experiences of resuming life after immunotherapy and associated survivorship care needs: A qualitative study among patients with metastatic melanoma. Br. J. Dermatol. 2022, 187, 381–391. [Google Scholar] [CrossRef]
- Haslam, A.; Gill, J.; Prasad, V. Estimation of the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugs. JAMA Netw. Open 2020, 3, e200423. [Google Scholar] [CrossRef]
- Marshall-McKenna, R.; Kotronoulas, G.; Kokoroskos, E.; Gil Granados, A.; Papachristou, P.; Papachristou, N.; Collantes, G.; Petridis, G.; Billis, A.; Bamidis, P.D.; et al. A multinational investigation of healthcare needs, preferences, and expectations in supportive cancer care: Co-creating the LifeChamps digital platform. J. Cancer Surviv. 2023, 17, 1094–1110. [Google Scholar] [CrossRef]
- Timmerman, J.G.; Tönis, T.M.; Weering, M.G.H.D.-V.; Stuiver, M.M.; Wouters, M.W.J.M.; van Harten, W.H.; Hermens, H.J.; Vollenbroek-Hutten, M.M.R. Co-creation of an ICT-supported cancer rehabilitation application for resected lung cancer survivors: Design and evaluation. BMC Health Serv. Res. 2016, 16, 155. [Google Scholar] [CrossRef]
- Olsson, M.; Eliasson, I.; Kautsky, S.; Segerstad, Y.H.A.; Nilsson, S. Co-creation of a digital platform for peer support in a community of adolescent and young adult patients during and after cancer. Eur. J. Oncol. Nurs. 2024, 70, 102589. [Google Scholar] [CrossRef]
- Yardley, L.; Morrison, L.; Bradbury, K.; Muller, I. The Person-Based Approach to Intervention Development: Application to Digital Health-Related Behavior Change Interventions. J. Med. Internet Res. 2015, 17, e30. [Google Scholar] [CrossRef]
- Zwanenburg, L.C.; van der Lee, M.L.; Koldenhof, J.J.; Suijkerbuijk, K.P.M.; Schellekens, M.P.J. What patients with advanced cancer experience as helpful in navigating their life with a long-term response: A qualitative study. Support. Care Cancer 2024, 32, 222. [Google Scholar] [CrossRef] [PubMed]
- Zwanenburg, L.C.; van Roekel, E.; Suijkerbuijk, K.P.M.; Koldenhof, J.J.; Schuurbiers-Siebers, O.C.J.; van der Stap, J.; van der Lee, M.L.; Schellekens, M.P.J. Resilience in advanced cancer patients who obtain a long-term response to immunotherapy or targeted therapy: An Ecological Momentary Assessment study. Ann. Beh. Med. 2025; in press. [Google Scholar]
- Zigmond, A.S.; Snaith, R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983, 67, 361–370. [Google Scholar] [CrossRef]
- Spinhoven, P.; Ormel, J.; Sloekers, P.P.A.; Kempen, G.I.J.M.; Speckens, A.E.M.; Van Hemert, A.M. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol. Med. 1997, 27, 363–370. [Google Scholar] [CrossRef]
- Smith, B.W.; Dalen, J.; Wiggins, K.; Tooley, E.; Christopher, P.; Bernard, J. The brief resilience scale: Assessing the ability to bounce back. Int. J. Behav. Med. 2008, 15, 194–200. [Google Scholar] [CrossRef]
- Leontjevas, R.; de Beek, W.; Lataster, J.; Jacobs, N. Brief Resilience Scale-Dutch Version [database record]. APA PsycTests 2014. [Google Scholar] [CrossRef]
- Bangor, A.; Kortum, P.T.; Miller, J.T. An Empirical Evaluation of the System Usability Scale. Int. J. Hum. Comput. Interact. 2008, 24, 574–594. [Google Scholar] [CrossRef]
- Ensink, C.J.; Keijsers, N.L.W.; Groen, B.E. Translation and validation of the System Usability Scale to a Dutch version: D-SUS. Disabil. Rehabil. 2024, 46, 395–400. [Google Scholar] [CrossRef] [PubMed]
- Billingham, S.A.; Whitehead, A.L.; Julious, S.A. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med. Res. Methodol. 2013, 13, 104. [Google Scholar] [CrossRef]
- Braun, V.; Clarke, V. Thematic Analysis: A Practical Guide; SAGE Publications: London, UK, 2022. [Google Scholar]
- Kamalumpundi, V.; Saeidzadeh, S.; Chi, N.-C.; Nair, R.; Gilbertson-White, S. The efficacy of web or mobile-based interventions to alleviate emotional symptoms in people with advanced cancer: A systematic review and meta-analysis. Support. Care Cancer 2022, 30, 3029–3042. [Google Scholar] [CrossRef]
- Hong, Y.A.; Hossain, M.M.; Chou, W.S. Digital interventions to facilitate patient-provider communication in cancer care: A systematic review. Psycho-Oncology 2020, 29, 591–603. [Google Scholar] [CrossRef]
- Hamama-Raz, Y.; Pat-Horenczyk, R.; Perry, S.; Ziv, Y.; Bar-Levav, R.; Stemmer, S.M. The Effectiveness of Group Intervention on Enhancing Cognitive Emotion Regulation Strategies in Breast Cancer Patients. Integr. Cancer Ther. 2016, 15, 175–182. [Google Scholar] [CrossRef] [PubMed]
- van Helmondt, S.J.; van der Lee, M.L.; van Woezik, R.A.M.; Lodder, P.; de Vries, J. No effect of CBT-based online self-help training to reduce fear of cancer recurrence: First results of the CAREST multicenter randomized controlled trial. Psycho-Oncology 2020, 29, 86–97. [Google Scholar] [CrossRef]
- Hyzy, M.; Bond, R.; Mulvenna, M.; Bai, L.; Dix, A.; Leigh, S.; Hunt, S. System Usability Scale Benchmarking for Digital Health Apps: Meta-analysis. JMIR mHealth uHealth 2022, 10, e37290. [Google Scholar] [CrossRef] [PubMed]
- Walsh, C.A.; Miller, S.J.; Smith, C.B.; Prigerson, H.G.; McFarland, D.; Yarborough, S.; Santos, C.D.L.; Thomas, R.; Czaja, S.J.; RoyChoudhury, A.; et al. Acceptability and usability of the Planning Advance Care Together (PACT) website for improving patients’ engagement in advance care planning. PEC Innov. 2024, 4, 100245. [Google Scholar] [CrossRef]
- Burgers, V.W.G.; Bent, M.J.v.D.; Rietjens, J.A.C.; Roos, D.C.; Dickhout, A.; Franssen, S.A.; Noordoek, M.J.; van der Graaf, W.T.A.; Husson, O. “Double awareness”—Adolescents and young adults coping with an uncertain or poor cancer prognosis: A qualitative study. Front. Psychol. 2022, 13, 1026090. [Google Scholar] [CrossRef]
- Kolsteren, E.E.M.; Deuning-Smit, E.; Prins, J.B.; van der Graaf, W.T.A.; Kwakkenbos, L.; Custers, J.A.E. Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment. J. Cancer Surviv. 2024. [Google Scholar] [CrossRef]
- Arantzamendi, M.; García-Rueda, N.; Carvajal, A.; Robinson, C.A. People With Advanced Cancer: The Process of Living Well With Awareness of Dying. Qual. Health Res. 2020, 30, 1143–1155. [Google Scholar] [CrossRef]
- Hayashi, Y.; Sato, K.; Ogawa, M.; Taguchi, Y.; Wakayama, H.; Nishioka, A.; Nakamura, C.; Murota, K.; Sugimura, A.; Ando, S. Association Among End-Of-Life Discussions, Cancer Patients’ Quality of Life at End of Life, and Bereaved Families’ Mental Health. Am. J. Hosp. Palliat. Med. 2022, 39, 1071–1081. [Google Scholar] [CrossRef]
Website Page | PE 1 Text | PE 1 Therapist Video | LTR Interview Video | Animation Video | Quotes | Exercises | Referral |
---|---|---|---|---|---|---|---|
1. Long-term responders | |||||||
1.1. When everything is uncertain… | |||||||
1.1.1. Living with uncertainty | X | X | X | X | |||
1.1.2. Fear that the disease will get worse | X | X | X | Mindfulness Conversation aid | |||
1.1.3. Monitoring your body | X | X | |||||
1.1.4. Your role in your care | X | X | X | ||||
1.2. The people surrounding you | |||||||
1.2.1. Talking about your disease | X | X | X | X | X | ||
1.2.2. Changes in daily life | X | X | Conversation aid | ||||
1.2.3. Contact with peers | X | X | X | ||||
1.3. Your old life and the end of life | |||||||
1.3.1. Saying goodbye to your old life | X | X | Conversation aid | ||||
1.3.2. Thinking about the end of life | X | X | X | Conversation aid | |||
1.4. Getting back on track | |||||||
1.4.1. Making changes | X | X | X | ||||
1.4.2. What matters to you | X | X | X | Value task | |||
1.4.3. Cancer and work | X | X | X | ||||
2. Close others | |||||||
2.1. Living long-term with cancer | X | X | |||||
2.2. Supporting a long-term responder | X | ||||||
2.3. Taking care of yourself | X | ||||||
3. I want to participate in research | X | X | |||||
4. I need help | X | X |
Topic | Questions |
---|---|
Design | How did you experience the design of the website? Did it appeal to you, or not? How did the design of the website make you feel? |
Usability | What do you think of the website’s navigation? How easy or difficult was the use of the website? How easily could you find information or content on the website? What do you think of the language used on the website? Was it appealing, or not? |
Feasibility | How did the content of the website make you feel? What page of the website was most appealing to you? What page of the website did you like the least? What would you change about the website? What did you miss on the website? |
Consequences | Did using the website help you? In what way? Have you been thinking, feeling or doing things differently after using the website? To what extent did you feel supported by using the website? Why? Would you visit the website again in the future? What for? |
Recommendation | Would you recommend the website to other LTRs? Why? Thinking back on your own diagnosis and treatment, what do you think is the best moment to visit this website? Why? Would you recommend your close others to visit the website? |
Closing | Is there anything else you would like to discuss? |
What was it like taking part in this interview? | |
Do you have any questions left about this study? |
n | (%) | |
---|---|---|
Age, mean (SD) | 57.23 | 8.75 |
Gender | ||
Male | 14 | 32.56 |
Female | 29 | 67.44 |
Educational level | ||
Practical | 1 | 2.33 |
Intermediate | 20 | 46.51 |
Theoretical | 22 | 51.16 |
Working status | ||
Employed/Student | 6 | 19.95 |
Disabled | 21 | 48.84 |
Sick | 8 | 18.61 |
Retired | 4 | 9.30 |
Volunteering | 4 | 9.30 |
Relationship status | ||
Single | 3 | 6.98 |
Married/Living together | 36 | 83.72 |
Divorced | 2 | 4.65 |
Widowed | 2 | 4.65 |
Severely distressed (HADS ≥15) | 16 | 37.21 |
Cancer type | ||
Lung cancer | 25 | 58.14 |
Melanoma | 9 | 20.93 |
Breast cancer | 7 | 16.28 |
Esophageal cancer | 1 | 2.33 |
Cervical cancer | 1 | 2.33 |
Time since diagnosis in months, mean (SD) | 45.56 | 32.70 |
Treatment | ||
Immunotherapy | 25 | 58.14 |
Targeted Therapy | 18 | 41.86 |
Themes and Subthemes on Positive Feedback | Quotes | Subthemes on Suggestions for Improvement | Quotes |
---|---|---|---|
1. Usability | |||
Calm colors and appropriate illustrations | “I think the website looks appealing. The green color gives it a natural look. It also feels like the continuation of life. It’s not overly somber; it is fresh like spring.” -woman (52), melanoma | Little use of color and childish illustrations | “I found the illustrations a bit childish. They’re clear and well-organized, but yeah... A lot of people are going to use it [the website]. They have all kinds of educational levels of course, so it has to be understandable for everyone, but because of that I sometimes found it a bit simple.” -woman (55), lung cancer |
Clear main themes | “It’s pretty clear, isn’t it? There are 4 clear chapters that you can go to.” -man (53), melanoma | Losing track due to many click options | “I find it challenging to stay on track. The website contains a lot of information and numerous referrals, making it hard to maintain an overview. I often wonder: Where am I now? How do I get back? Should I continue with a related subtopic?” -woman (55), lung cancer |
Accessible, concise, and personal in language/tone | “The tone of voice of the website felt warm and familiar.” -man (57), lung cancer | Sometimes impersonal or too directive in language/tone | “What bothered me a bit was: ‘are you struggling with this? then this is a solution.’ As if someone has the wisdom on how to deal with this. I prefer offering options or possibilities. Yeah, well, I don’t think this happened often, but every now and then I came across something like this.” -woman (55), lung cancer |
2. Acknowledgement and Normalization | |||
Attention for LTRs | “What I found most appealing is the attempt to get close to the patients.” -man (63), lung cancer | Limited attention paid to close others | “Just as there are all kinds of videos for the patients, they should also be there for their close others. They also want recognition and confirmation and perhaps a little encouragement like ‘hey, we see you’. Yes, because they really have it just as hard, don’t they? Because they have to do all that extra stuff and watch someone else being really sick, which causes a lot of sadness. Plus, 80% of the people ask them: hey, how is the patient? That’s pretty lonely. So it would be really cool if you had a website that says: hey, how are you?” -woman (49), lung cancer |
Acknowledging difficulties | “Wow… finally, someone describes exactly how I feel!” -woman (59), lung cancer | Not acknowledging difficulties with checking your body | “On the page ‘checking your body’ there is actually nothing acknowledging, for example that it is really complicated to analyze how your body feels. So, you want someone to analyze how the body feels, but how? It is a complicated thing, isn’t it?” -woman (54), lung cancer |
Finding recognition in peer experiences | “I was especially drawn to the stories of peers. It’s comforting to realize that we form a unique group.” -man (53), melanoma | ||
Co-creation with LTRs | “The website connects with people who are sick and are sentenced to death again and again and still live, just like me... You can simply see that the website was built by such people.” -man (46), melanoma | ||
The term “LTR” provides hope | “The word ‘doorleven’ (literally: continue living) has the most impact on me. You are not dead, you are going to live with cancer.” -man (63), lung cancer | ||
3. Tailored Information | |||
Specialized website referrals | “The explanations are clear, particularly the references to sites that discuss the topics in more depth, preventing the need to reinvent the wheel.” -woman (49), breast cancer | Lack of focus on living | “In addition to the motto ‘be always prepared,’ I also embrace the saying ‘So far, so good!’ I feel that this positive perspective is somewhat missing from the site. An LTR continues their life, and that’s wonderful!” -man (52), melanoma |
Research references | “The scientific research is very valuable. On the website you can read what happens behind the scenes. I do not search the internet that much, because you often end up on things that do not apply to you. Now, I have a direct site that is reliable and that is about you and fellow patients.” -man (66), melanoma | Lack of specific information | “I am ill and have young children… How do other young mothers manage parenting while dealing with illness, especially when it comes to the thought of leaving their children behind?” -woman (39), lung cancer |
Clear psycho-education | “The website does make it clear that it [living with advanced cancer] has a huge impact on people, and I think that’s good. I’m a bit more light-hearted by nature, but I think it’s good that it’s clear here, because it can also end badly. I think the texts are good.” -woman (62), lung cancer | ||
Accessible animated videos | “I found the videos useful and easy to follow, because they are in animation form and don’t take long to watch. The movies are nice, short, and concise, in which the important things are touched upon.” -woman (62), breast cancer | ||
4. Tools | |||
Provided tools | “The questions of the conversation aid were most appealing to me. It’s nice to have these questions and to think about them.” -woman (24), cervical cancer | Lack of interaction | “I miss the opportunity to interact and respond. Having that feature would motivate me to visit the website repeatedly.” -man (62), lung cancer |
Inform close others | “I really came across things on the website ‘yes that is exactly what I feel, that is exactly what I also come across’. I immediately thought something like I have to tell my father and my husband, and my close others to read that website, and you should not go to the page for loved ones, but for the LTR and read that.’” -woman (39), lung cancer | ||
Providing hope | “I would probably offer the website a few months after the diagnosis, because there are things on it that are nice to read. You can see the website as something hopeful, because you can read that people often live longer.” -woman (62), lung cancer | ||
Input for reflection and discussion | “My close others also found it complicated: ‘You’re cured, aren’t you? Yeah, what’s your problem?’ Of course, that’s not how they react. But I think that’s what they think. Of course, that’s not true. Due to the conversation aid, I think it’s a good idea to have that conversation again with my family, my friends. We don’t have to give a daily health update anymore: am I dying yet? But it’s like: I’m not completely back yet or something. Cancer still plays a role.” -woman (52), melanoma | ||
Sense of reality | “I thought it was good that all those quotes were on there, no matter how heavy they are, because they are really from people who have cancer too. Look, if you deal with it the way I do, then ehm you might also have the tendency to make it a bit too small sometimes. But in this way I do have support from peers who are going through the same thing. So it was helpful to read those quotes.” -man (53), melanoma | ||
5. Recommendation to Other LTRs | |||
Clear recommendation | “I would definitely recommend the website. It is a beautiful website and very valuable. There is a lot of information and references to even more information that directly relate to LTRs. And if I speak for myself, there was a lot of recognition and I got practical tips that I plan to act on. Reading all this can be confronting at times. Sometimes you may not want to, but it becomes part of the new you.” -man (66), melanoma | Cautious recommendation | “It depends on the person and what they are doing. Many things I read were recognizable but did not provide any new insights. I feel that I have found a balance in life. However, by focusing on the illness or reading a lot on the site about topics that no longer concern me (for example, thinking about the end of life), that balance was sometimes disturbed. I don’t feel like dwelling on that. Sometimes, I even felt a bit irritated by the ready-made answers.” -woman (55), lung cancer |
Use shortly after diagnosis | “I think the website is a very good user manual for those who are newly palliative. I have been palliative for a long time and have already figured everything out myself. I see this website as a guide.” -woman (62), lung cancer | ||
Use at various times | “There are of course different themes on the website, which are relevant at different times. For the moment just before a scan, there is a heading about how to deal with stress, so I would read that then. Furthermore, at times when I am busy with everything I still have to arrange for the last phase of my life, I would also look at the website.” -woman (24), cervical cancer |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zwanenburg, L.C.; van der Lee, M.L.; Koldenhof, J.J.; van der Stap, J.; Suijkerbuijk, K.P.M.; Schellekens, M.P.J. The Co-Creation of a Psychosocial Support Website for Advanced Cancer Patients Obtaining a Long-Term Response to Immunotherapy or Targeted Therapy. Curr. Oncol. 2025, 32, 284. https://doi.org/10.3390/curroncol32050284
Zwanenburg LC, van der Lee ML, Koldenhof JJ, van der Stap J, Suijkerbuijk KPM, Schellekens MPJ. The Co-Creation of a Psychosocial Support Website for Advanced Cancer Patients Obtaining a Long-Term Response to Immunotherapy or Targeted Therapy. Current Oncology. 2025; 32(5):284. https://doi.org/10.3390/curroncol32050284
Chicago/Turabian StyleZwanenburg, Laura C., Marije L. van der Lee, José J. Koldenhof, Janneke van der Stap, Karijn P. M. Suijkerbuijk, and Melanie P. J. Schellekens. 2025. "The Co-Creation of a Psychosocial Support Website for Advanced Cancer Patients Obtaining a Long-Term Response to Immunotherapy or Targeted Therapy" Current Oncology 32, no. 5: 284. https://doi.org/10.3390/curroncol32050284
APA StyleZwanenburg, L. C., van der Lee, M. L., Koldenhof, J. J., van der Stap, J., Suijkerbuijk, K. P. M., & Schellekens, M. P. J. (2025). The Co-Creation of a Psychosocial Support Website for Advanced Cancer Patients Obtaining a Long-Term Response to Immunotherapy or Targeted Therapy. Current Oncology, 32(5), 284. https://doi.org/10.3390/curroncol32050284